M. Yamamoto et al., HALOTHANE AND ISOFLURANE ATTENUATE THE RELAXANT RESPONSE TO NONADRENERGIC AND NONCHOLINERGIC NERVE-STIMULATION OF ISOLATED CANINE CEREBRAL-ARTERIES, Anesthesia and analgesia, 86(3), 1998, pp. 552-556
Stimulation of nonadrenergic noncholinergic (NANC) nerves elicits rela
xation of canine cerebral arteries via the nitric oxide (NO)-cGMP path
way. The purpose of this study was to investigate the effects of halot
hane and isoflurane on the relaxant response of isolated canine cerebr
al arteries to NANC nerve stimulation. The isometric tension of isolat
ed canine cerebral arteries, which had been denuded of endothelium, wa
s measured in a tissue bath. The application of transmural electrical
stimulation (TES) at a frequency of 5 Hz elicited a transient relaxati
on of arteries partially contracted with prostaglandin F-2 alpha. This
effect was abolished by treatment with N-G-nitro-L-arginine (3 x 10(-
5) M), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (10(-5) M), or tetr
odotoxin (10(-6) M). Treatment with halothane (2.3%) or isoflurane (2.
3% and 3.5%) attenuated the relaxant response to TES (P < 0.05). Halot
hane (2.3%) but not isoflurane (2.3% and 3.5%) attenuated relaxation i
nduced by s-nitro-N-acetylpenicillamine. We suggest that halothane and
isoflurane inhibit cerebroarterial vasodilation mediated via NO-cGMP
pathway activated by stimulation of the NANC nerves. The sites of acti
on of halothane and isoflurane on the NO-cGMP pathway may differ. Impl
ications: Nonadrenergic noncholinergic nerves play a role in the regul
ation of vascular tone in cerebral arteries via the nitric oxide-cGMP
pathway. This study showed that, in isolated canine cerebral arteries,
halothane and isoflurane inhibit the relaxation caused by nonadrenerg
ic noncholinergic nerve stimulation, but their sites of action may dif
fer.